The association between cardiovascular medication use and survival in patients with advanced pancreatic adenocarcinoma
Mavros MN, Ladak F, Chan KKW, Nguyen L, Coburn NG, Raphael MJ. Ther Adv Med Oncol. 2026; 18:17588359261449094.
Publications
Head and neck cancers medical costs in a universal health system: a population-based case-control study
Villemure-Poliquin N, Fu R, Chan KKW, Li Q, Ayoo K, Wright F, Karam I, Coburn NG, Hallet J, Eskander A. J Otolaryngol Head Neck Surg. 2026; Feb 14 [Epub ahead of print].
Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphoma
Kordbacheh T, Chan KK, Crump M, Ante Z, Liu N, Aminilari M, Gong IY, Bhella S, Vijenthira A, Kuruvilla J, Kridel R, Chen C, Kukreti V, Yang C, Hodgson D, Prica A, Rodin D. Blood Adv. 2026; Jan 16 [Epub ahead of print].
Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: a real-world population-based descriptive study
Dai WF, Nguyen L, Liu N, Chan KK. Oral Oncol. 2026; 173:107851. Epub 2026 Jan 8.
Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario
Suleman A, Ante Z, Liu N, Crump M, Chan KKW, Cheung MC, Prica A. Blood Neoplasia. 2026; 3(2): 100184. Epub 19 Nov 2025.
Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Palliative care with tracheostomy or gastrostomy tube use and end-of-life quality and costs among patients with head and neck cancer
Fu R, Sutradhar R, Li Q, Villemure-Poliquin N, Chan KKW, Karam I, Hallet J, Eskander A. JAMA Otolaryngol Head Neck Surg. 2025; Sep 25 [Epub ahead of print].
Development of machine learning systems to predict cancer-related symptoms with validation across a health care system
Yuan B, Kabir M, He JC, Li Y, Grant B, Narine S, Welch M, Podolsky S, Liu N, Ajaj R, Zhan LJ, Fawzy A, Xu J, Zhang Y, Yu V, Xu W, Krishnan RG, Gallinger S, Chan KKW, Krzyzanowska MK, Truong T, Liu G, Grant RC. JCO Clin Cancer Inform. 2025; 9:e2500073. Epub 2025 Sep 25.
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Hoang T, Cheung MC, Juurlink DN, Chan KKW, Lau C, Liu N, Abdel-Qadir H, Prica A, Hay AE, Vijenthira A, Mozessohn L. Br J Haematol. 2025; Aug 29 [Epub ahead of print].
Predicting chronic kidney disease after cisplatin treatment using population-level data
Grant RC, He JC, Liu N, Podolsky S, Notta F, Ghassemi M, Gallinger S, Knezevic A, Latcha S, Jaimes E, Kitchlu A, Chan K. JAMA Oncol. 2025; 11(10): 1179-1185.